Navigation Links
WuXi AppTec Bioanalytical Services Unit Receives GLP Certificate from OECD and EU
Date:8/23/2011

SHANGHAI, Aug. 23, 2011 /PRNewswire-Asia/ -- WuXi AppTec announced today that its Bioanalytical Services (BAS) unit had received a certificate of Good Laboratory Practice (GLP) from the Organization for Economic Cooperation and Development (OECD) and the European Union (EU).  

The certificate states that WuXi's BAS facility in Shanghai is able to carry out ADME (absorption, distribution, metabolism, and excretion) studies, toxicokinetic and pharmacokinetic studies, and hERG assay and biomarker studies with respect to OECD and EU principles of Good Laboratory Practice.  Award of the certificate followed a thorough review of the facility operations and records on May 9-11, 2011, by Belgian authorities.  

This represents WuXi's third successful audit of its bioanalytical lab by regulatory authorities.  The facility also passed a bioequivalence study inspection by the U.S. Food and Drug Administration (FDA) in March 2009 and an inspection by China's State Food and Drug Administration (SFDA) supporting the certification of WuXi's GLP toxicology operation in Suzhou.  The BAS laboratory is now certified by the SFDA and OECD to provide GLP-compliant support for nonclinical studies.  In addition, this laboratory is certified by the OECD to support clinical trials for small-molecule and biologics pharmacokinetics and biomarker analysis.

WuXi's Bioanalytical Services (BAS) was established in 2005.  BAS provides GLP-compliant services to analyze small-molecule drugs using liquid chromatography/mass spectroscopy and to measure biomarker/biologics and antibody immunogenicity using immunochemistry.  It is the only bioanalytical laboratory in China to have passed SFDA, OECD, and FDA GLP inspections.

"We are very pleased to have passed this OECD/EU inspection," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec.  "WuXi will continue to pursue the highest levels of quality and transparen
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
2. Cetero Research Names Dr. Roger Hayes President of Bioanalytical Operations
3. QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India
4. MicroConstants Completes Installation of Latest LC/MS/MS Technology to Achieve Improved Sensitivity in Bioanalytical Method Development
5. PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011
6. PharmaNets Bioanalytical Laboratory Recognized by the Standards Council of Canada for Good Laboratory Practice Compliance
7. PharmaNet Names Dr. George Scott Vice President of Bioanalytical Services
8. West Pharmaceutical Services, Inc. Appoints New Director
9. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
10. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
11. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015   Decision Resources ... retinal specialists identify less frequent dosing as the ... due to the burden on both patients and ... growth factor (VEGF) injections, which are the current ... abicipar pegol, which is in development for dosing ...
(Date:7/2/2015)... July 2, 2015  Konica Minolta, Inc. (Konica Minolta) ... it has acquired Sawae Technologica Ltda., an X-ray system ... , through its Brazilian healthcare sales company, Konica ... Local Brazil market investment ... population exceeding 200 million, significant healthcare technical advancements and ...
(Date:7/2/2015)...  AbbVie (NYSE: ABBV ) will announce its ... before the market opens. AbbVie will host ... 8 a.m. Central time (9 a.m. Eastern). It will ... www.abbvieinvestor.com . An archived edition of the call will ... About AbbVie AbbVie is a global, research-based ...
Breaking Medicine Technology:Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... , , , THOUSAND ... AMGN ) today announced that new data will be presented ... Prolia(TM) (denosumab) at the 2009 American Society for Bone and ... 2009. Prolia currently is being evaluated by regulatory bodies ...
... LEVADEX Analysis Shows Potential to ... Migraine is a common, debilitating ... United States, according to the,National Headache Foundation. Limitations of ... migraines, include slow onset of,significant pain relief between 45 ...
Cached Medicine Technology:Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 2Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 5Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 6Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 7Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 8MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS 2
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... The opening is the first sweetFrog store located in Mississippi. The premium frozen yogurt ... in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS 38652, ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was ... , The store, which opened July 1 at Duke’s Travel Plaza, is located at:, ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Edwards (D-Md.) for her introduction of the Stop Overdose Stat (S.O.S.) Act of ... Senator Jack Reed (D-R.I.), this Act seeks to decrease drug overdose – especially ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Many Fourth of ... mind. That’s why Amica Insurance is sharing some tips to promote the ... approximately 230 people go to the emergency room daily with fireworks-related injuries in the ...
(Date:7/2/2015)... , ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift ... alone. He sat down to write his first poem, and three years later he was ... was special and worth sharing with the world. "I have always believed that the best ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... , PITTSBURGH, Aug. 18 ... Matrix Laboratories, an Indian company in which Mylan owns a ... and Drug Administration (FDA) under the President,s Emergency Plan for ... for a fixed-dose combination (FDC) of Efavirenz, Emtricitabine, Tenofovir Disoproxil ...
... ELM GROVE, Wis., Aug. 18 Long wait times can ... safety . Many hospitals constantly struggle with moving patients in need of critical ... bed. Compirion Healthcare Soluti o ns is ... Improving Patient Flow - ED to Inpatient , free of charge ...
... Aug. 18 From Nurse Jackie to Obama and ... market -- from Saatchi & Saatchi Wellness -- offers a daily dose ... So, what makes this blog different from all others? , ... people working here and they have a lot to say," says Jim ...
... , , BALTIMORE, Aug. 18 ... an Ocular Services Division to replace the Tissue Distribution and Information Center ... will continue to provide a high level of customer service to ophthalmic ... and TBI operations divisions. , , ...
... , JACKSONVILLE, Fla., Aug. 18 The ... Cross and Blue Shield of Florida (BCBSF), announced today that it ... funding from Partners Investing in Nursing,s Future , a unique ... across the country. To date, this is the first Florida organization ...
... EDISON, N.J., Aug. 18 Digitek Medication ... heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial flutter), ... that even a slight increase in dosage can be toxic or fatal. ... suffered digitalis toxicity or symptoms associated with digitalis toxicity as a result ...
Cached Medicine News:Health News:Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment 2Health News:Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 2Health News:Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 3Health News:Saatchi & Saatchi Wellness' Hot New Blog: Pertinent, Poignant and Anything but Boring 2Health News:Tissue Banks International Develops Expanded Ocular Services Division 2Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 2Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 3Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 4Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 5Health News:Digitek Medication Recalled Due to Risk of Digitalis Toxicity 2
... decade KMI® revolutionized the wrist arthroplasty market ... Wrist System. We're at it again, with ... the Universal2. Like the original, the Universal2 ... live with debilitating arthritis. To date, we ...
... Carl Zeiss has successfully advanced into the ... success of this instrument is by no ... and stylish design. Maximum ergonomic convenience is ... be used with a surgical microscope, allowing ...
Athroscopic leg holder system....
The 300 watt Xenon light source will provide intense illumination necessary for demanding, advanced endoscopic procedures....
Medicine Products: